Want to take quizzes and track your credits?
Coronavirus disease 2019 (COVID-19) is a global pandemic that has led to diversion of resources to the front lines and postponement of elective procedures. Patients with structural heart disease are a high-risk cohort because of their age and comorbidities. Management of their underlying condition has sometimes been delayed as a result of efforts to avoid community and health care setting exposure to COVID-19. An executive order was enacted by the New York State government on March 22, 2020, leading to cancellation of elective procedures. We describe here the outcomes of patients with symptomatic, severe aortic stenosis (AS) from our structural heart disease program during the COVID-19 pandemic.
Sign in to take quiz and track your certificates
Accepted for Publication: July 27, 2020.
Published: September 30, 2020. doi:10.1001/jamanetworkopen.2020.19801
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Ro R et al. JAMA Network Open.
Corresponding Author: Stamatios Lerakis, MD, PhD, Division of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, One Gustave L. Levy Place, New York, NY 10029 (email@example.com).
Author Contributions: Drs Ro and Lerakis had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Khera, Kini, Lerakis.
Acquisition, analysis, or interpretation of data: Ro, Khera, Tang, Krishnamoorthy, Sharma, Lerakis.
Drafting of the manuscript: Ro, Krishnamoorthy, Lerakis.
Critical revision of the manuscript for important intellectual content: Khera, Tang, Sharma, Kini.
Statistical analysis: Krishnamoorthy, Lerakis.
Administrative, technical, or material support: Khera, Tang, Sharma.
Supervision: Khera, Tang, Kini, Lerakis.
Conflict of Interest Disclosures: Dr Khera reported being a consultant for Abbott, Medtronic, and Boston Scientific, and receiving speakers’ honoraria from Medtronic. Dr Tang reported being a physician proctor for Medtronic and a consultant for Medtronic, Abbott Structural Heart, and W. L. Gore & Associates. No other disclosures were reported.
Additional Contributions: Malcolm Anastasius, MBBS, PhD (Mount Sinai Hospital), provided assistance with data analysis; he was not compensated for this work.
You currently have no searches saved.